Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMCSamsungVolvo

3-Point Analysis | Why AstraZeneca's COVID vaccine may be more suitable for India than Pfizer, Moderna shots

Watch the video to find out how a dosing error turned into a lucky punch for AstraZeneca and Oxford.

November 24, 2020 / 02:40 PM IST
In another promising development in the quest to end the pandemic, a COVID-19 vaccine developed by Oxford-AstraZeneca has prevented a majority of people from getting the disease in a large trial. Watch the video to find out how a dosing error turned into a lucky punch for AstraZeneca and Oxford.
Moneycontrol News
first published: Nov 24, 2020 02:40 pm
Sections